Review of NICE Technology Appraisal Guidance No 152; drug-eluting stents for the treatment of coronary artery disease (part review of TA71)

The Institute was proposing that the consideration to review the existing guidance should be deferred until June 2012.

During consultation, the majority of comments received by the Institute agreed with the proposal put forward. After consideration of all of the comments (attached as appendix A), the Institute’s Guidance Executive has decided to proceed with the proposal. We will therefore defer the review of the original guidance until 2012. At this point the evidence base will again be assessed to ascertain the need for a review of the current guidance.

October 2010